Citigroup Inc. acquired a new stake in shares of SI-Bone Inc (NASDAQ:SIBN) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,200 shares of the company’s stock, valued at approximately $46,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of SIBN. Strs Ohio bought a new position in SI-Bone during the 4th quarter valued at $48,000. Victory Capital Management Inc. bought a new position in SI-Bone during the 4th quarter valued at $261,000. TD Asset Management Inc. bought a new position in SI-Bone during the 4th quarter valued at $300,000. Dean Capital Investments Management LLC bought a new position in SI-Bone during the 4th quarter valued at $625,000. Finally, BlackRock Inc. bought a new position in SI-Bone during the 4th quarter valued at $15,835,000. Hedge funds and other institutional investors own 39.45% of the company’s stock.

SI-Bone stock opened at $17.63 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 14.73 and a current ratio of 15.11. SI-Bone Inc has a 1 year low of $16.27 and a 1 year high of $23.03. The stock has a market capitalization of $434.39 million and a PE ratio of -24.83.

SI-Bone (NASDAQ:SIBN) last posted its quarterly earnings results on Thursday, March 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.20) by ($0.02). The firm had revenue of $15.62 million for the quarter. On average, research analysts expect that SI-Bone Inc will post -0.86 earnings per share for the current year.

Separately, Zacks Investment Research downgraded shares of SI-Bone from a “hold” rating to a “sell” rating in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $24.75.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/citigroup-inc-acquires-new-position-in-si-bone-inc-sibn/2953963.html.

About SI-Bone

SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Further Reading: Return on Investment (ROI)

Want to see what other hedge funds are holding SIBN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SI-Bone Inc (NASDAQ:SIBN).

Institutional Ownership by Quarter for SI-Bone (NASDAQ:SIBN)

Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.